Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Editas Medicine (EDIT) Non Operating Income: 2015-2025

Historic Non Operating Income for Editas Medicine (EDIT) over the last 11 years, with Sep 2025 value amounting to -$569,000.

  • Editas Medicine's Non Operating Income fell 116.14% to -$569,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.6 million, marking a year-over-year decrease of 108.66%. This contributed to the annual value of $14.1 million for FY2024, which is 11.92% down from last year.
  • Latest data reveals that Editas Medicine reported Non Operating Income of -$569,000 as of Q3 2025, which was up 67.63% from -$1.8 million recorded in Q2 2025.
  • In the past 5 years, Editas Medicine's Non Operating Income ranged from a high of $5.1 million in Q3 2023 and a low of -$1.8 million during Q2 2025.
  • Its 3-year average for Non Operating Income is $2.5 million, with a median of $3.5 million in 2024.
  • Its Non Operating Income has fluctuated over the past 5 years, first spiked by 1,456.32% in 2022, then crashed by 140.92% in 2025.
  • Over the past 5 years, Editas Medicine's Non Operating Income (Quarterly) stood at $174,000 in 2021, then skyrocketed by 1,456.32% to $2.7 million in 2022, then spiked by 87.89% to $5.1 million in 2023, then slumped by 76.45% to $1.2 million in 2024, then tumbled by 116.14% to -$569,000 in 2025.
  • Its Non Operating Income stands at -$569,000 for Q3 2025, versus -$1.8 million for Q2 2025 and -$425,000 for Q1 2025.